GPOH Phase I/II Network Southwest
Pediatric Oncology and Hematology
The GPOH Network Southwest promotes the access to innovative therapies in early clinical trials for children with malignancies in the southwest region of Germany.
Innovative therapies for affected children
The Network Southwest is a nonprofit organization. Our mission is to
provide the best possible support for science and research. We want to improve
the care of children with malignancies, especially where standard therapies have
failed.
Clinical trials with high reliability
Our coordinating office enables close management between all partners
involved in early clinical trials. We support administrative processes and
ensure that early clinical trials are smoothly conducted and completed in
compliance with all relevant guidelines and standards.
Strong partners with common goals
The Network Southwest unites 13 independent institutions for pediatric
hematology and oncology, all members of the GPOH. The network ensures a
collegial exchange with each other and a quick transfer of knowledge for the
benefit of the patients.
Contact: Please feel free to contact us.
The right contact person for your project?
Please contact us to find highly experienced partners to conduct planned clinical trials.
GPOH Phase I/II Network Southwest at a glance
13 Centers for pediatric oncology, all members of the GPOH
Part of the European network
4 designated ITCC-centers
20
20 open clincial trials
SPECIALIZATION
in early clinical trials (PHASE I AND II)
in pedatric oncology and hematology
Central coordination office for the management of clinical trial requests
News
Clinical trial with Gilteritinib for patients with FLT3/ITD-positive AML opens in Freiburg
14.12.2020In September 2020, a phase I/II trial with Gilteritinib (ASP2215) for the treatment of children, adolescents and young adults with a FLT3/ITD-positive refractory or progressive AML has been launched at the center Freiburg.